We would like to introduce you to the Innovative Health Initiative (IHI) funded project PaLaDIn (Patient Lifestyle and Disease Data Interactium)! PaLaDIn will develop and implement an innovative data collection platform to accelerate the development of effective treatments and patient care, enhance healthcare decision-making and improve patient outcomes. PaLaDIn is committed to enhancing healthcare outcomes for individuals with neuromuscular and other rare diseases through the development of ‘The Interactium®,’ a global, patient-centric data platform. By gathering comprehensive patient data on health status and experiences, we ensure that patients’ voices are integral to healthcare decision-making. Our platform aims to accelerate the development of effective treatments, improve patient-reported outcome measures (PROMs), and inform healthcare decisions. Ultimately, we strive to share our insights and tools to benefit other rare diseases, empowering patients and advancing better healthcare outcomes. But how will the ambitious project do this? David Allison and Neil Bennett from PaLaDIn scientific coordinator TREAT-NMD talked to us about why this project is highly needed and how it could benefit patients with neuromuscular and other rare diseases. Click on the questions below to hear more:
